Global Allergy Rhinitis Drugs Market 2017-2021

  • ID: 4240191
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Adamis Pharmaceuticals
  • Ampio
  • AstraZeneca
  • Genentech
  • Hanmi Pharmaceuticals
  • Novartis
  • MORE

About Allergy Rhinitis Drugs

Allergic rhinitis refers to the inflammation of nasal membranes that causes nasal congestion, sneezing, itching, and rhinorrhea. This condition is usually caused by dust, animal dander, pollen, and certain food ingredients. Allergic rhinitis or hay fever occurs when the immune system overreacts to allergens in the air such as dust, animal dander, or pollen. Symptoms can also occur due to various food allergies.

The analysts forecast the global allergy rhinitis drugs market to grow at a CAGR of 3.05% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global allergy rhinitis drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Allergy Rhinitis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- GlaxoSmithKline
- Sanofi
- ALK-Abelló
- Meda Pharmaceuticals

Other prominent vendors
- Adamis Pharmaceuticals
- Allergy Therapeutics
- Almirall
- Ampio
- AstraZeneca
- Amneal Pharmaceuticals
- Anergis
- Apotex
- Array BioPharma
- Aspen Pharmacare
- Circassia Pharmaceuticals
- Dr Reddy's Laboratories
- Eddingpharm
- EMS
- HAL Allergy
- Inmunotek
- Genentech
- Greer Laboratories
- Glenmark Pharmaceuticals
- Hanmi Pharmaceuticals
- Hisamitsu Pharmaceutical
- Intas Pharmaceuticals
- Novartis
- Nuvo Research
- Nycomed
- Omega Pharma
- Shionogi
- Stallergenes
- Sun Pharmaceuticals
- Takeda
- Teva Pharmaceuticals
- Verona Pharma
- VentiRx Pharmaceuticals

Market drivers
- Increasing awareness about allergic rhinitis
- For a full, detailed list, view the full report

Market challenges
- Patent expiries and generic competition
- For a full, detailed list, view the full report

Market trends
- Increase in R&D activities
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the Key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Adamis Pharmaceuticals
  • Ampio
  • AstraZeneca
  • Genentech
  • Hanmi Pharmaceuticals
  • Novartis
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Pipeline Landscape

PART 06: Market landscape
  • Market overview
PART 07: Market segmentation by drug class
  • Global allergy rhinitis antihistamines market
  • Global allergy rhinitis intranasal corticosteroids market
  • Global allergy rhinitis immunotherapies market
  • Others
PART 08: Geographical segmentation
  • Allergy rhinitis drugs market in Americas
  • Allergy rhinitis drugs market in EMEA
  • Allergy rhinitis drugs market in APAC
PART 09: Decision framework

PART 10: Drivers and challenges
  • Market drivers
  • Market challenges
PART 11: Market trends
  • Strategic alliances
  • Increase in R&D activities
  • Self-medication using OTC products
PART 12: Vendor landscape
  • GlaxoSmithKline
  • Sanofi
  • ALK-Abelló
  • Meda Pharmaceuticals
  • Other prominent vendors
PART 13: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Types of allergic rhinitis
Exhibit 02: Risk factors associated with allergic rhinitis
Exhibit 03: Key pipeline candidates by vendor and number of drugs
Exhibit 04: Pipeline analysis
Exhibit 05: Global allergy rhinitis drugs market snapshot
Exhibit 06: Global allergy rhinitis drugs market 2016-2021 ($ millions)
Exhibit 07: Five forces analysis
Exhibit 08: Global allergy rhinitis drugs market: Segmentation by drug class
Exhibit 09: Global allergy rhinitis antihistamines market 2016-2021 ($ millions)
Exhibit 10: Global allergy rhinitis intranasal corticosteroids market 2016-2021 ($ millions)
Exhibit 11: Global allergic rhinitis immunotherapies market 2016-2021 ($ millions)
Exhibit 12: Global allergy rhinitis drugs market by geography 2016 and 2021
Exhibit 13: Global allergy rhinitis drugs market revenue by geography 2016-2021 ($ millions)
Exhibit 14: Market scenario in Americas
Exhibit 15: Allergy rhinitis drugs market in Americas ($ millions)
Exhibit 16: Market scenario in EMEA
Exhibit 17: Allergy rhinitis drugs market in EMEA 2016-2021 ($ millions)
Exhibit 18: Market scenario in APAC
Exhibit 19: Allergy rhinitis drugs market in APAC 2016-2021 ($ millions)
Exhibit 20: Drugs that underwent prescription-to-OTC switch in the US
Exhibit 21: Competitive structure analysis of global allergy rhinitis drugs market 2016
Exhibit 22: GlaxoSmithKline: Key highlights
Exhibit 23: GlaxoSmithKline: Strength assessment
Exhibit 24: GlaxoSmithKline: Strategy assessment
Exhibit 25: GlaxoSmithKline: Opportunity assessment
Exhibit 26: Sanofi: Key highlights
Exhibit 27: Sanofi: Strength assessment
Exhibit 28: Sanofi: Strategy assessment
Exhibit 29: Sanofi: Opportunity assessment
Exhibit 30: ALK-Abelló: Key highlights
Exhibit 31: ALK-Abelló: Strength assessment
Exhibit 32: ALK-Abelló: Strategy assessment
Exhibit 33: ALK-Abelló: Opportunity assessment
Exhibit 34: Meda Pharmaceuticals: Key highlights
Exhibit 35: Meda Pharmaceuticals: Strength assessment
Exhibit 36: Meda: Strategy assessment
Exhibit 37: Meda: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Adamis Pharmaceuticals
  • Ampio
  • AstraZeneca
  • Genentech
  • Hanmi Pharmaceuticals
  • Novartis
  • MORE
New Report Released: – Global Allergy Rhinitis Drugs Market 2017-2021

The author of the report recognizes the following companies as the key players in the global allergy rhinitis drugs market: GlaxoSmithKline, Sanofi, ALK-Abelló and Meda Pharmaceuticals.

Other Prominent Vendors in the market are: Adamis Pharmaceuticals, Allergy Therapeutics, Almirall, Ampio, AstraZeneca, Amneal Pharmaceuticals, Anergis, Apotex, Array BioPharma, Aspen Pharmacare, Circassia Pharmaceuticals, Dr Reddy's Laboratories, Eddingpharm, EMS, HAL Allergy, Inmunotek, Genentech, Greer Laboratories, Glenmark Pharmaceuticals, Hanmi Pharmaceuticals, Hisamitsu Pharmaceutical, Intas Pharmaceuticals, Novartis, Nuvo Research, Nycomed, Omega Pharma, Shionogi, Stallergenes, Sun Pharmaceuticals, Takeda, Teva Pharmaceuticals, Verona Pharma and VentiRx Pharmaceuticals.

Commenting on the report, an analyst from the research team said: “One trend in the market is increase in R&D activities. Allergic diseases are one of the fastest-growing chronic diseases globally. If not managed properly at an early stage, allergic diseases such as rhinitis can increase the risk of asthma in the later stage of life. Several organizations around the world work to better understand the pathogenesis of allergic diseases.”

According to the report, one driver in the market is increasing awareness about allergic rhinitis. The increasing awareness about allergic rhinitis is fueling the market growth. Due to various environmental factors, the prevalence of allergic rhinitis is increasing in US. In the US, awareness programs and initiatives are undertaken by various organizations to spread disease awareness among the target population. Asthma and Allergy Foundation of America (AAFA) observes May as the National Asthma and Allergy Awareness Month and April is observed as the Allergic Rhinitis Awareness Month. The organization conducts several events such as fundraising programs, conferences, and online events.

Further, the report states that one challenge in the market is patent expiries and generic competition. The patent expiry of major drugs approved for allergy rhinitis is expected to adversely affect the market and slow down its growth during the forecast period. The patent expiry of a drug often results in the loss of the exclusive market, leading to a rapid decline in sales. Drugs that lose patent protection become open to generic competition. Generics have been gathering an increasing share of the market for allergy rhinitis drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • GlaxoSmithKline
  • Sanofi
  • ALK-Abelló
  • Meda Pharmaceuticals
  • Adamis Pharmaceuticals
  • Allergy Therapeutics
  • Almirall
  • Ampio
  • AstraZeneca
  • Amneal Pharmaceuticals
  • Anergis
  • Apotex
  • Array BioPharma
  • Aspen Pharmacare
  • Circassia Pharmaceuticals
  • Dr Reddy's Laboratories
  • Eddingpharm
  • EMS
  • HAL Allergy
  • Inmunotek
  • Genentech
  • Greer Laboratories
  • Glenmark Pharmaceuticals
  • Hanmi Pharmaceuticals
  • Hisamitsu Pharmaceutical
  • Intas Pharmaceuticals
  • Novartis
  • Nuvo Research
  • Nycomed
  • Omega Pharma
  • Shionogi
  • Stallergenes
  • Sun Pharmaceuticals
  • Takeda
  • Teva Pharmaceuticals
  • Verona Pharma VentiRx Pharmaceuticals
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll